We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
E-learning modules for healthcare professionals on minimising the risks of using medicines and information on how to access medical device modules.
Guidance on the submission, processing and assessment of all completed paediatric studies sponsored by marketing authorisation holders (MAHs).
How to apply for an exceptional use authorisation to place medical devices on the UK market.
Information for patients, healthcare professionals and developers of new medicines
Also covering requests for waivers or deferrals and concerning the operation of the compliance check.
A step-by-step guide on using the MORE Platform for Submissions of device related incidents.
How to comply with the regulatory requirements for manufacturing custom-made medical devices.
How to notify the MHRA that you are going to undertake a clinical investigation of a medical device.
Details of the process changes for established medicines, effective from 1 March 2024, which apply specifically to chemical products.
An interpretation of the good manufacturing practice (GMP) requirements for specials manufacturers.
Information on the new regulations for the post-market surveillance of medical devices which come into effect on 16 June 2025.
How new recommendations could make healthcare AI safer, clearer and fairer for patients, professionals, providers and developers across the UK.
A step-by-step guide on using the MORE Platform for Registrations for Submissions of device related incidents.
The MHRA’s AI Airlock second phase ran between April 2025 and May 2026. This report does not constitute formal MHRA guidance.
UK guideline on GMP for decentralised manufacturing, ensuring compliance with EU GMP principles for safe, quality medicinal products.
Clinical trial applications that need expert advice from a specialist group or committee.
Anyone in Northern Ireland selling medicines to the public via a website must still comply with the requirement to apply the EU common logo.
The Early Access to Medicines Scheme (EAMS) aims to give patients with life threatening or seriously debilitating conditions early access to medicines that show early signs of having a major advantage over existing therapeut…
The MHRA accepts an Active Substance Master File and/or a Certificate of Suitability in both new national initial Marketing Authorisation Applications (MAA) and in Marketing Authorisation Variation (MAV) applications.
Provides a standard framework for NHS procurement professionals to assess non-financial value when buying medical technology.
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).